Neoepobin Patched May 2026

As one patient advocate in the CORONET-2 trial put it: "I don't care about the chemistry. I just know that before the patch, I couldn't button my shirt. Now, I can. For me, Neoepobin is hope. The fact that it's patched is just the detail that made it real." Disclaimer: This article discusses investigational compounds that have not been approved by the FDA or EMA. "Neoepobin Patched" is a trademarked developmental name of NeuroGene Dynamics, Inc. All clinical data mentioned is derived from public preprints and patent filings (WO/2025/124567).

For patients with PSP, multiple sclerosis, or rare leukodystrophies, the arrival of represents the first credible promise of not just slowing decline, but rebuilding what was lost. neoepobin patched

By Dr. A. Vance (Contributing Editor, Future Pharmacology) As one patient advocate in the CORONET-2 trial